Роль Витекса священного (Vitex agnus castus) в гинекологической эндокринологии
- Авторы: Вуттке В1, Зайдлова-Вуттке Д1, Ярри Г1, Артымук Н2
-
Учреждения:
- Университет Геттингена, Германия
- ГБОУ ВПО Кемеровская государственная медицинская академия Минздравсоцразвития РФ
- Выпуск: Том 14, № 1 (2012)
- Страницы: 8-11
- Раздел: Статьи
- URL: https://ogarev-online.ru/2079-5831/article/view/33221
- ID: 33221
Цитировать
Полный текст
Аннотация
Об авторах
В Вуттке
Университет Геттингена, ГерманияУниверситет Геттингена, Германия
Д Зайдлова-Вуттке
Университет Геттингена, ГерманияУниверситет Геттингена, Германия
Г Ярри
Университет Геттингена, ГерманияУниверситет Геттингена, Германия
Н Артымук
ГБОУ ВПО Кемеровская государственная медицинская академия Минздравсоцразвития РФГБОУ ВПО Кемеровская государственная медицинская академия Минздравсоцразвития РФ
Список литературы
- Wuttke W, Gorkow C, Seidlova-Wuttke D. Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study. Menopause 2006; 13: 185-96.
- Wuttke W, Jarry H, Christoffel V et al. Chaste tree (Vitex agnus-castus) - pharmacology and clinical indications. Phytomedicine 2003; 10: 348-57.
- Gorkow C, Wuttke W. Evidence of efficacy of Vitex agnus castus preparations. Phytopharmaka V 1999; p. 189-208.
- Halaska M, Raus K, Beles P et al. Treatment of cyclical mastodynia using an extract of Vitex agnus castus: results of a double-blind comparison with a placebo. Ceska Gynekol 1998; 63: 388-92.
- Wuttke W, Splitt G, Gorkow C et al. Behandlung zyklusabhängiger Brustschmerzen mit einem Agnus castus-haltigen Arzneimittel-Ergebnisse einer randomisierten, plazebokontrollierten Doppelblindstudie. Geburtsh u Frauenheilk 1997; 57: 569-74.
- Kubista E, Muller G, Spona J. Treatment of mastopathies with cyclic mastodynia. Clinical results and hormonal profiles. Rev Fr Gynecol Obstet 1987; 82: 221-7.
- Kumar S, Mansel RE, Hughes LE et al. Prediction of response to endocrine therapy in pronounced cyclical mastalgia using dynamic tests of prolactin release. Clin Endocrinol (Oxf) 1985; 23: 699-704.
- Suginami H, Ito T, Hamada K et al. Serum prolactin levels during sleep and in metoclopramide stimulation in normoprolactinemic anovulation and ovulation induction with bromocriptine. Nippon Sanka Fujinka Gakkai Zasshi 1986; 38: 728-34.
- Wuttke W, Pitzel L, Seidlova-Wuttke D et al. LH pulses and the corpus luteum: the luteal phase deficiency LPD. Vitam Horm 2001; 63: 131-58.
- Freeman ME, Kanyicska B, Lerant A et al. Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000; 80: 1523-631.
- Dogliotti L, Mansel RE. Bromocriptine treatment of cyclical mastalgia/fibrocystic breast disease: update on the European trial. Br J Clin Pract Suppl 1989; 68: 26-32; dis. 49-53.
- Nazli K, Syed S, Mahmood MR et al. Controlled trial of the prolactin inhibitor bromocriptine (Parlodel) in the treatment of severe cyclical mastalgia. Br J Clin Pract 1989; 43: 322-7.
- Schwibbe M BD, Wuttke W. EEG and psycho-logical effects of lisuride in women with premenstrueal tension. Lisurides and Other Dopmanine Agonists. Calne et al. 1983.
- Milewicz A, Gejdel E, Sworen H et al. Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study. Arzneimittelforschung 1993; 43: 752-6.
- Wuttke W GC, Jarry H. Dopaminergic compounds in Vitex agnus castus. Phyto-Pharmaka-Forschung und klinische Anwendung 1995; p. 81-91.
- Jarry H, Leonhardt S, Gorkow C et al. In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Exp Clin Endocrinol 1994; 102: 448-54.
- Ono M, Nagasawa Y, Ikeda T et al. Three new diterpenoids from the fruit of Vitex agnus castus. Chem Pharm Bull (Tokyo) 2009; 57: 1132-5.
- Christoffel V, Spengler B, Jarry H et al. Prolactin inhibiting dopaminergic activity of diterpenes from Vitex agnus castus Phytopharmaka 1999; p. 209-14.
- Artymuk NV. Vitex agnus castus extract administered for luteal-phase defect treatment. J Reproduktionsmed Endokrinol 2010; 7: 362.
- Gerhard II, Patek A, Monga B et al. MastodynonR bei weiblicher Sterilitat. Forsch Komplementarmed 1998; 5: 272-8.
- Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ 2001; 322: 134-7.
- Prilepskaya VN. Vitex agnus castus: Successful treatment of moderate to severe premenstrual syndrome. Maturitas 55S 2006; p. 55-63.
- Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol 2003; 18: 191-5.
- Bogorad RL, Courtillot C, Mestayer C et al. Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors. Proc Natl Acad Sci USA 2008; 105: 14533-8.
- Courtillot C, Chakhtoura Z, Bogorad R et al. Characterization of two constitutively active prolactin receptor variants in a cohort of 95 women with multiple breast fibroadenomas. J Clin Endocrinol Metab 1995; p. 271-9.
- Daniele C, Thompson Coon J, Pittler MH et al. Vitex agnus castus: a systematic review of adverse events. Drug Saf 2005; 28: 319-32.
Дополнительные файлы
